Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Elisabeth M. C. Dequeker

The Relevance of External Quality Assessment for Molecular Testing for ALK Positive Non-Small Cell Lung Cancer: Results From Two Pilot Rounds Show Room for Optimization

PLoS ONE
Multidisciplinary
2014English

ISO 15189-Accredited Laboratories Fulfill the JCI Hospital Accreditation Standard Requirements for the Use of Referral Laboratories: Report of a Consensus Meeting

Accreditation and Quality Assurance
InstrumentationRiskReliabilitySafetyChemical EngineeringChemistryQuality
2016English

Related publications

Brigatinib for ALK-positive Metastatic Non-Small-Cell Lung Cancer: Design, Development and Place in Therapy

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2019English

P1.01-043 Molecular Testing for Non-Small Cell Lung Cancer in Latin American

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

ALK Inhibition for Non-Small Cell Lung Cancer: From Discovery to Therapy in Record Time

Cancer Cell
Cancer ResearchOncologyCell Biology
2010English

Cost-Effectiveness of ALK Testing and First-Line Crizotinib Therapy for Non-Small-Cell Lung Cancer in China

PLoS ONE
Multidisciplinary
2018English

Updates Regarding Biomarker Testing for Non–Small Cell Lung Cancer: Considerations From the National Lung Cancer Roundtable

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

Differential Crizotinib Response Duration Among ALK Fusion Variants in ALK-Positive Non–Small-Cell Lung Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2016English

Quality-Of-Care Indicators for Non-Small Cell Lung Cancer

Cancer Control
MedicineOncologyHematology
2009English

How Should We Treat Alectinib-Refractory ALK-Positive Non–Small Cell Lung Cancer?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Pcn198 - An Economic Systematic Literature Review (Slr) for Anaplastic Lymphoma Kinase-Positive (Alk+) Non-Small-Cell Lung Cancer (Nsclc)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy